Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...
Những tác giả chính: | Jayne, DR, Rasmussen, N |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
1997
|
Những quyển sách tương tự
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Bằng: Mukhtyar, C, et al.
Được phát hành: (2006) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
Bằng: Rohini Handa
Được phát hành: (2018-01-01) -
Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
Bằng: John Chuan Nguyen Tran, et al.
Được phát hành: (2022-12-01) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Bằng: Flossmann, O, et al.
Được phát hành: (2006) -
Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
Bằng: Brendan L. Thoms, et al.
Được phát hành: (2021-07-01)